# CircRNA UBAP2 serves as a sponge of miR-1294 to increase tumorigenesis in hepatocellular carcinoma through regulating c-Myc expression

- **DOI:** [10.1093/carcin/bgab068](https://doi.org/10.1093/carcin/bgab068)
- **Rating:** Sound (3.2 out of 5)
- **Verdict:** A competent circRNA mechanism study that extends HCC biology, but remains constrained by single-center validation.
- **Framework version:** v5.0
- **Pipeline version:** v0.4
- **Evaluation date:** 2026-07-09
- **Evaluation page:** https://www.nabu.science/paper/10.1093%2Fcarcin%2Fbgab068

## Strengths

- **Mechanism tested through multiple assays** The proposed sponge mechanism is supported by cytoplasmic localization, luciferase assays, AGO2 RIP, miRNA pull-down, circRNA pull-down, western blotting, and rescue experiments. This provides more triangulation than a simple expression-association study.
  - Dimension: methodological rigour
  - Location: Results pp.7-9; Figures 4-6
- **Clinical association adds translational relevance** The study measures circUBAP2 in 125 HCC tissues and reports associations with overall survival, time to recurrence, vascular invasion, and differentiation. Multivariate Cox analyses report circUBAP2 as independently associated with TTR and OS.
  - Dimension: application pathway
  - Location: Results p.6; Tables 1-3
- **Clear disease-context novelty claim** The discussion distinguishes prior circUBAP2 work in other cancers and frames the HCC-specific circUBAP2/miR-1294/c-Myc axis as the gap addressed here. That makes the contribution legible even though the mechanism class is familiar.
  - Dimension: contribution
  - Location: Discussion pp.9-10; References 22-31

## Limitations

- **External validation is not provided** The prognostic claim relies on a single-center surgical cohort and a 20-pair tissue validation subset. No independent cohort, patient-derived model, or broader clinical setting is used to test generalisability.
  - Dimension: methodological rigour
  - Location: Methods p.4; Results p.6; Figure 1
- **In vivo reporting lacks key details** The xenograft methods do not report group sizes, randomisation, blinding, or detailed statistical handling, and the text alternates between nude mice and NOG mice. This limits confidence in the animal-model evidence supporting the functional claims.
  - Dimension: methodological rigour
  - Location: Methods, Xenograft mouse model p.6; Results p.7; Figure 2F
- **Reporting inconsistencies reduce precision** The results include a heading stating that circUBAP2 induces apoptosis even though the experiments indicate the opposite direction, and the figure legends contain panel-labeling and cross-reference inconsistencies. These do not overturn the main argument but weaken reporting reliability.
  - Dimension: reporting
  - Location: Results pp.7-9; Figure 3 legend p.20; Figure 4 legend p.21

## Reliability checks

Caveats (4 of 4 checks).

- **Internal coherence:** Noted. The central circUBAP2/miR-1294/c-Myc mechanism is broadly coherent, but reporting precision is reduced by figure-labeling, cross-reference, animal-model, and statistical-description inconsistencies. These are watch-outs for interpretation and reproducibility rather than evidence that the core results are invalid.
- **Research conduct:** Noted. Human consent and human/animal ethics approvals are declared, but approval identifiers are not reported. Data availability is limited to an in-article statement, with no external repository or raw quantitative dataset identified.
- **Reference integrity:** Clean. All 50 cited references resolved to real publications via PubMed, Crossref, or OpenAlex.
  - References not verified automatically are resolved manually within 24 hours.

## Post-publication record

- **Status:** Clean
- **Summary:** No retraction or expression of concern found in Crossref (includes Retraction Watch).
- **Last checked:** 2026-10-17
